223 related articles for article (PubMed ID: 15585413)
1. IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Chan L; Hardwick N; Darling D; Galea-Lauri J; Gäken J; Devereux S; Kemeny M; Mufti G; Farzaneh F
Mol Ther; 2005 Jan; 11(1):120-31. PubMed ID: 15585413
[TBL] [Abstract][Full Text] [Related]
2. Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune responses.
Koya RC; Kasahara N; Pullarkat V; Levine AM; Stripecke R
Leukemia; 2002 Sep; 16(9):1645-54. PubMed ID: 12200676
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.
Hirst WJ; Buggins A; Darling D; Gäken J; Farzaneh F; Mufti GJ
Gene Ther; 1997 Jul; 4(7):691-9. PubMed ID: 9282170
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
Cayeux S; Richter G; Becker C; Beck C; Aicher A; Pezzutto A; Dörken B; Blankenstein T
Eur J Immunol; 1997 Jul; 27(7):1657-62. PubMed ID: 9247574
[TBL] [Abstract][Full Text] [Related]
5. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
Todo T; Martuza RL; Dallman MJ; Rabkin SD
Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
[TBL] [Abstract][Full Text] [Related]
6. Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect.
Liu X; Zhang L; Zhang M; Ma Y; Xu X; Cai Y
Chin Med J (Engl); 2000 Feb; 113(2):167-71. PubMed ID: 11775545
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of immune recognition molecules by interleukin-7 in human acute leukaemias.
Costello RT; Mallet F; Chambost H; Sainty D; Gastaut JA; Olive D
Eur Cytokine Netw; 1999 Mar; 10(1):87-96. PubMed ID: 10210778
[TBL] [Abstract][Full Text] [Related]
8. Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myeloma.
Wen XY; Mandelbaum S; Li ZH; Hitt M; Graham FL; Hawley TS; Hawley RG; Stewart AK
Cancer Gene Ther; 2001 May; 8(5):361-70. PubMed ID: 11477456
[TBL] [Abstract][Full Text] [Related]
9. A triad of costimulatory molecules synergize to amplify T-cell activation.
Hodge JW; Sabzevari H; Yafal AG; Gritz L; Lorenz MG; Schlom J
Cancer Res; 1999 Nov; 59(22):5800-7. PubMed ID: 10582702
[TBL] [Abstract][Full Text] [Related]
10. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
[TBL] [Abstract][Full Text] [Related]
11. Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells.
Dessureault S; Graham FL; Gallinger S
Cancer Gene Ther; 1999; 6(3):195-208. PubMed ID: 10359205
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.
Wendtner CM; Nolte A; Mangold E; Buhmann R; Maass G; Chiorini JA; Winnacker EL; Emmerich B; Kotin RM; Hallek M
Gene Ther; 1997 Jul; 4(7):726-35. PubMed ID: 9282174
[TBL] [Abstract][Full Text] [Related]
13. A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes.
Sulé-Suso J; Arienti F; Melani C; Colombo MP; Parmiani G
Eur J Immunol; 1995 Oct; 25(10):2737-42. PubMed ID: 7589065
[TBL] [Abstract][Full Text] [Related]
14. B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.
Lu ZY; Condomines M; Tarte K; Nadal L; Delteil MC; Rossi JF; Ferrand C; Klein B
Exp Hematol; 2007 Mar; 35(3):443-53. PubMed ID: 17309825
[TBL] [Abstract][Full Text] [Related]
15. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
16. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
17. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
[TBL] [Abstract][Full Text] [Related]
18. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
19. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]